Tag: ACBFF

CBD Market Set for Huge Growth

CannabisNewsWire Editorial Coverage: In a fragile economic world, industries with significant growth forecast are certain to catch the eye of savvy investors looking for just the right place to be. Recent reports indicate that the cannabidiol (CBD) market is estimated to grow by 700 percent by 2020, and a report by market intelligence firm Hemp Business Journal projects that the CBD market will grow to $2.1 billion by 2020 (http://cnw.fm/7iczS), an astronomical jump in value compared to last year’s CBD market of $202 million. This news bodes well for hemp-focused companies such as Marijuana Company of America (OTC: MCOA) (MCOA Profile), whose hempSMART™ brand will be among the first CBD products to be marketed on a mass national TV commercial. Growth in hemp-based products is only a piece of the cannabis industry puzzle. The entire legal cannabis industry is expected to hit $57 billion by 2027, with recreational marijuana use making up 67 percent of that and medical marijuana use taking up the remaining 33 percent. Other companies positioning themselves to take advantage of this incredible growth include AbbVie, Inc. (NYSE: ABBV), CV Sciences, Inc. (OTCQB: CVSI), KushCo Holdings, Inc. (OTCQB: KSHB), and Aurora Cannabis, Inc (OTCQX: ACBFF).

Capitalizing on the Power of CBD

Studies show that cannabidiol (CBD) possesses an array of therapeutic benefits, including antioxidant and neuroprotective properties. One of more than 85 cannabinoids identified in marijuana and hemp, CBD is typically used for health reasons and, unlike the more widely recognized compound tetrahydrocannabinol (THC), is not psychoactive, meaning it doesn’t cause a high. CBD products can be derived from industrial hemp plants or marijuana plants.

Marijuana Company of America (MCOA Profile), an industrial hemp company, has capitalized on the power of CBD through its product research and development of legal hemp-based consumer products under the hempSMART brand, which targets general health and well-being. The products, which include drops and creams, are formulated to produce the finest botanical supplements on the market, derived from industrial hemp containing CBD compounds that help support the bodies endocannabinoid system.

A National Market Strategy and TV Commercial

 Earlier this month, MCOA announced (http://cnw.fm/WxIg1) that it had engaged Kim Castle of Verve Integrative to create a market strategy and manage a direct response television ad campaign to promote its hempSMART product line. Initially, hempSMART will be working with Verve Integrative to develop a market strategy and television commercial for its hempSMART Full Spectrum Pet Drops, which will air on cable networks this summer. The commercial spot will have featured placement on the official ecommerce site of a popular direct-response TV company and will be broadly promoted on integrated social media outlets.

“We are very pleased to partner with hempSMART on their journey to bring such thoughtful and well-developed products to the people who need natural relief and enhanced health solutions. I wish hempSMART™ Pet Drops were available to support my cherished dog when we were going through a health challenge together,” said Castle, who, along with her team, bring more than 25 years of experience in many variations of media strategy, development and production. Their clients include Disney, GM, ABC, Paramount, and Grey Group.

The team specializes in multipoint story experiences designed to educate, entertain and endorse while mirroring the human mind’s process of solving a problem, thereby supporting consumers in making emotional and logical product conclusions. Castle’s experience provides an invaluable edge to the hempSMART marketing campaign. Castle has also been an outspoken advocate of CBD as an alternative to traditional products currently on the market.

MCOA CEO Donald Steinberg noted that “Kim’s experience gives us an excellent opportunity to greatly expand the marketing strategy for the hempSMART brand and product line. We are honored that the hempSMART product line will be managed by her and the Verve Integrative team. We look forward to the new television commercial airing this summer.”

Pet Supplement Market Expanding

MCOA just launched its hempSMART Full Spectrum Pet Drops in February. The new specially formulated product contains naturally occurring CBD derived from hemp seed oil, full spectrum hemp extract, and fractionated coconut oil, along with a rich bacon flavor.

Sales of natural pet supplement sales nearly doubled between 2008 and 2011, and with an increasing focus on pet health, the market for pet supplements is projected to show significant and continuing expansion (http://cnw.fm/66NhV). Estimates show that U.S. retail sales of pet supplements and nutraceutical treats will grow 3 to 5 percent annually, bringing the market to almost $1.6 billion. Globally, the pet supplement market is also expected to experience tremendous growth.

Steinberg said, “Our new hempSMART product is a natural option for pet owners who care about supporting their animals’ healthy energy levels as well as optimizing their health. Our hempSMART product line will continue to expand to other popular areas of consumer interest to give our affiliates what they need to succeed.”

Wellness Environment Shifting toward CBD

The wellness industry is growing rapidly, generating an estimated $3.72 trillion annually (http://cnw.fm/d3Zs5). In addition, the attitude in the wellness environment is shifting regarding premium quality cannabinoid products. MCOA is one of the prominent companies working to give consumers access to technological innovations and the highest quality hemp-derived products.

Specifically designed to support normal bodily functions such as energy, flexibility, and overall wellness, hempSMART products are only the beginning for MCOA and its hempSMART division. MCOA is committed to find, test, and deliver the finest natural ingredients focused on wellness and personal care combined with the added benefits of hemp-based cannabinoids.

In addition to dedicating itself to the development of CBD-based nutritional products, MCOA is focused on educating and empowering consumers to learn about and become part of the hemp movement, thus allowing its customers to benefit from some of the world’s most innovative hemp products. The company is also dedicated to supporting the resurgence of green sustainable hemp-based products and technologies that have a positive effect on the environment.

Others Positioning in the Market

MCOA isn’t the only company deeply committed to making its presence felt in the burgeoning hemp and cannabis industries.

AbbVie (NASDAQ: ABBV) is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. With a cannabis-based drug already available on the market, pharmaceutical company AbbVie, is ahead of the pack in this industry. Its FDA-approved Marinol is approved for chemotherapy-induced nausea and vomiting and anorexia, and the drug may also help AIDS patients who have lost their desire to eat.

CV Sciences, Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD, and a consumer product division in manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The company’s PlusCBD Oil™ has achieved immense success since the launch of its brand of dietary supplements. The brand is currently being sold in approximately 1,300 health food stores and continues to grow its shelf presence in various retail outlets across the country. “It’s evident that hemp-derived CBD products are doing better and growing faster than almost every other category in the supplement industry, and it’s been a long time since we’ve seen a supplement trend truly demonstrate demand in such an immense fashion,” said Stuart Tomc, vice president of human nutrition and spokesperson for CV Sciences. “There are no barriers to acceptance as the idea of hemp-derived CBD is finally ripe. Consumers are embracing hemp-derived CBD.”

The premier packaging company in the rapidly growing legal, regulated marijuana industry, KushCo Holdings, Inc. (OTCQB: KSHB) is a dynamic sales and distribution platform that provides packaging, supplies, vaporizer products, hydrocarbons, accessories, and branding services to cannabis manufacturers, processors and retailers. Founded in 2010, Kush Bottles now has 12 facilities throughout the United States, a sales presence in every major cannabis market, and strives to be the go-to supplier and thought leader for businesses in the cannabis industry. KushCo recently announced that it had partnered with MainStem, a technology-based ancillary product distribution company for the regulated cannabis industry, to be the inaugural partner for MainStem’s Vendor Program (MVP).

An industry leading producer of medical cannabis, Aurora Cannabis, Inc (OTCQX: ACBFF) operates a 55,200-square-foot, state-of-the-art production facility in Mountain View County, Alberta, and a second 40,000-square-foot, high-technology production facility in Pointe-Claire, Quebec. In January 2018, Aurora’s 800,000 square-foot-flagship cultivation facility located at the Edmonton International Airport was licensed. When at full capacity, this facility is expected to produce over 100,000 kg per annum of cannabis. Aurora is also completing a facility in Lachute. In addition, the company just announced its intention to acquire MedReleaf Corp. (TSX: LEAF). This proposed transaction will bring together two of Canada’s premier cannabis companies with fully aligned strategic visions and production philosophies, as well as complementary assets, distribution networks, products, and capabilities. The combined company will meet what Aurora and MedReleaf management teams consider to be the critical success factors in the industry, creating a powerful platform for accelerated growth on a global scale.

For more information about Marijuana Company of America, please visit Marijuana Company of America (MCOA).

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

CBD Solid Bedrock as US Heads Back to Industrial Hemp Roots

CannabisNewsWire Editorial Coverage: With the announcement in April of the Industrial Hemp Farming Act of 2018, the industry could be looking at a federal redefinition of hemp. Industrial hemp is a great source for CBD (cannabidiol), a non-psychoactive cannabinoid with numerous medical applications ranging (http://cnw.fm/7tqIy). U.S. market projections for hemp range from $1.9 to $2.1 billion within the next two years and could hit $3 billion by 2021, according to one industry analyst (http://cnw.fm/MLA5w). This is great news for well-positioned sector players such as Marijuana Company of America (OTC: MCOA) (MCOA Profile), which recently executed a sizeable hemp-cultivation JV agreement. Other similarly positioned companies, such as Vancouver’s Aurora Cannabis, Inc. (ACB.TO) (OTCQX: ACBFF), UK-based GW Pharmaceuticals Plc (NASDAQ: GWPH), Medical Marijuana, Inc. (OTC: MJNA) and Rocky Mountain High Brands, Inc. (OTCQB: RMHB), are also in position to exploit the burgeoning CBD market.

If passed alongside companion House Bill 5485, the Hemp Farming Act would effectively remove hemp from regulation as a controlled Schedule 1 substance, restoring the plant’s historic status as an important U.S. agricultural commodity. With Senate Minority Leader Chuck Schumer and fellow Democrat Senator Michael Bennet from Colorado signing on to the Hemp Farming Act with Republican Senator Cory Gardner from Colorado, the bill now looks to have strong bipartisan support. A recent report from Brightfield Group issued prior to the announcement of the Hemp Farming Act estimated that the hemp-derived CBD products component of the hemp market alone could hit $1 billion by 2020 (http://cnw.fm/Z9l9K). Industrial hemp has a storied history in America, having been cultivated from Colonial times through World War II and being essential to war efforts throughout that period. Given that the plant is a robust source for strong natural fiber and oils used to make everything from canvas and rope to building materials and fuel, it seems likely that the nation will indeed see the plant returned to its historical status as a core agricultural commodity.

Cultivation and Legal CBD Enable Agile Positioning

In an industry run by pioneering industry veterans who have lived through the legislative ups and downs that have ebbed and flowed since the earliest days of the cannabis market, the looming passage of the Cannabis Act in Canada and the potential of legislation such as the Marijuana Justice Act in the United States are encouraging signs that the industry has rounded the corner into the home stretch on legalization. CEO of Marijuana Company of America (MCOA Profile) Don Steinberg actually founded the first publicly traded U.S. marijuana company, Medical Marijuana Incorporated. MCOA already has a strong hand in the rapidly emerging market for industrial hemp-based CBD products, as well as its strategic cultivation-focused JV with B.C.-based Global Hemp Group that began in New Brunswick Canada last year and which has now expanded to 125 acres of commercial production.

The tip of the spear for MCOA in CBD is wholly owned subsidiary hempSMART™, whose affiliate marketing program and shrewdly engineered networking architecture, as well as upcoming major marketing campaigns that include a sixty second are designed to not only capture maximum market share but bolster customer retention as well. An offering such as hempSMART’s patent-pending “hempSMART Brain” product, which is designed to support healthy brain function, is an arguably compelling exploitation of CBD’s increasingly apparent antioxidant and neuroprotective functions (http://cnw.fm/Vh8bo).

Capacity Is Key Moving Forward

The recent JV agreement between MCOA and Global Hemp Group (which also has base operations in Montreal and Los Angeles) focused on cultivation of legal, high-yielding CBD from industrial hemp at a newly acquired 109-acre farm in Scio, Oregon. This move should significantly enhance the company’s market presence (http://cnw.fm/Owe9r). With the purchase of 20,000 high-yield CBD clones along with onsite clone production to meet an early June planting schedule target, assessment of key greenhouse technologies needed to maximize floor space and enable the JV’s perpetual harvest model, as well as the purchase of an additional 12,096 square feet of greenhouses for an intial total of nearly 20,000 square feet of production space, the JV is well on its way to having a superb high-yield CBD project in one of the country’s most cannabis-friendly states.

Additionally, the company recently announced completion of an initial 10,000 square foot greenhouse just south of the Canadian border in Washington State, developed via JV with agricultural services company Bougainville Ventures (http://cnw.fm/m8GaT). This first leg of a planned 30,000-square-foot facility is a major step towards realizing a sizeable production facility in a key jurisdiction that will become the home of several licensed tenants that will be looking for just such an ideal turnkey solution to satisfy their growing needs.

Sector Outlook Grounded in CBD and Biopharma

A strong footing in the already legal CBD market with the infrastructure to also potentially supply the growing medical and recreational markets throughout North America has put MCOA on the radar of many sector analysts. Savvy investors will want to compare the company’s rapidly expanding footprint with that of other sector players that also stand to benefit from pending legislative reform.

Aurora Cannabis, Inc. (ACB.TO) (OTCQX: ACBFF), a licensed Canadian producer of medical cannabis, recently estimated that it will surpass 90,000 kg of output by the end of this year and see revenues of around $70 million. With an 800,000-square-foot flagship facility at the Edmonton International Airport (estimated to be able to produce 100,000 kg of cannabis a year at full capacity), a 55,200-square-foot facility in Alberta, and another 40,000-square foot facility in Quebec, Aurora is uniquely positioned to become a major supplier that may even surpass rival Canopy Growth (WEED.TO) (OTC: TWMJF), which recently moved to list its shares on the NYSE. Moreover, Aurora’s plan to buy all common shares of MedReleaf (LEAF.TO) (OTC: MEDEFF), if approved, would create a true industry juggernaut, one estimated by financial services firm Canaccord Genuity to have the potential to eventually produce a whopping 570,000 kg of cannabis per year.

GW Pharmaceuticals Plc (NASDAQ: GWPH) is one of the most well-established cannabis biopharmaceutical companies in the space today, boasting a proprietary cannabinoid product platform that has given rise to such highly publicized indications as the anti-seizure CBD-based drug Epidiolex®. Along with its U.S. subsidiary Greenwich Biosciences, the company recently announced publication in The New England Journal of Medicine of Phase 3 study results of its oral CBD drug in a form of rare childhood-onset epilepsy known as Lennox-Gastaut syndrome. Many sector analysts argue that the NDA for GWPH’s oral CBD solution in Lennox-Gastaut and (similar) Dravet syndromes is likely to be approved by the FDA. Such an approval would mean the drug could become available by prescription in the the United States in the second half of 2018.

Medical Marijuana, Inc. (OTC: MJNA) portfolio companies Hempmeds®, Kannaway and Kannalife™ Sciences have been receiving more and more coverage of its internationalized distribution of products such as Real Scientific Hemp Oil™. The company’s CEO, Dr. Stuart Titus, was recently featured as part of a Buzzfeed article on CBD that reached a massive audience, even as the company’s portfolio company, HempMeds Brasil, was in the news for sponsoring the upcoming medical marijuana-focused “A Look into the Future” International Medicinal Seminar. That announcement came just days after the news that HempMeds has partnered with Northshore Pharmacy in Bermuda to sell the company’s flagship CBD oil products.

Rocky Mountain High Brands, Inc. (OTCQB: RMHB) recently announced that hemp products in its new and cutting-edge CBD-infused product line, known as HEMPd, are available for purchase on both Amazon and eBay. The company’s popular and naturally flavored energy drinks, Rocky Mountain High Hemp Infused Beverages, have been doing solid business in Canada since the initial one million can order shipped back in 2016. Rocky Mountain High is looking forward to potentially enjoying some serious momentum as Canada moves towards legalization, with one of the most widely recognized brands today in functional hemp food and drink. A roughly $3.6 million deal executed late last year with a major food and beverage distributor in Mexico, where marijuana is soon to be legalized, means RMHB looks to be well on its way to becoming one of the leading hemp-infused food and beverage purveyors on earth.

Sector Sentiment Appears Positive to Many Analysts

While there were major concerns for the cannabis sector last year and earlier this year, companies poised to exploit CBD and broader cannabis demand are eyeing the softening tone in the United States, as well as forthcoming Canadian legalization of all cannabis, as major boons to the industry. For a company such as MCOA, which has good access to the North American market and an established presence in CBD, the best may be yet to come.

For more information about Marijuana Company of America, please visit Marijuana Company of America (MCOA).

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Details Cannabis Exportation Agreement for Sol-gel Research

  • Permits obtained for importation of cannabis into Australia
  • PreveCeutical conducting research at University of Queensland for cannabinoid-based Sol-gel products
  • Cannabis-based Sol-gel products targeted at relieving symptoms such as pain, inflammation, seizures and neurological disorders

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), a health sciences company aiming to become a preventive health sciences leader, has announced the grant of three permits from the Australian government’s Department of Health allowing for the importation of cannabis into Australia for purposes of research. The permits, which have been granted to the Pharmacy Australia Centre of Excellence (PACE) at the University of Queensland, will allow PACE to import cannabis plant material shipments for research purposes. Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (FSE: 21P) (WKN: A1C4WM) will export the cannabis to PACE and has obtained the necessary Canadian permits to do so. Once shipped by Aurora, the cannabis will be used in PreveCeutical’s drug delivery research program for its Sol-gel (soluble gel).

The Sol-gel drug delivery research program, which is being undertaken at the University of Queensland, targets the development of a system that will enhance the bioavailability of drugs using a nose-to-brain delivery system. The program is being conducted by PreveCeutical’s research partner, UniQuest Pty Inc., and is being led by PreveCeutical Chief Research Officer Dr. Harendra Parekh.

The intention of PreveCeutical is to apply its Sol-gel technology to cannabinoids for the development of therapies to relieve a variety of symptoms, including pain, inflammation, seizures and neurological disorders. The permits obtained by PACE will allow PreveCeutical to test various cannabis strains for the development and commercialization of cannabinoid-based Sol-gels. Sol-gels boast a variety of advantages over traditional liquid nasal sprays, offering longer therapeutic effects, lower dosage requirements and a reduction in irritation and other unwanted side effects.

In consideration of its cannabis shipment for the research program, Aurora Cannabis has been granted certain rights, including an option to either license (on a nonexclusive basis) the Sol-gel technology for Canada and Australia or to choose a royalty arrangement on product sales, along with an option to purchase PreveCeutical shares. Part of Aurora’s strategy in becoming involved with PreveCeutical’s initiatives is gaining access to cannabis-based products that are more narrowly targeted at specific therapeutic areas but with a higher value add.

For more information, visit the company’s website at www.PreveCeutical.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Secures Australian Importation Permit in Support of Research into Sol-gels

  • Research will be conducted at PACE, a leading pharmaceutical research center in Australia
  • PreveCeutical’s unique technology promises to be the first FDA-approved, CBD-based nose-to-brain delivery system using a Sol-gel platform
  • Groundbreaking technology outstrips the benefits of any other delivery mechanism

On March 13, 2018, PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and Aurora Cannabis Inc. (OTCQB: ACBFF) (TSX: ACB) (FSE: 21P) announced that they had received three permits for the importation of cannabis plant material into Australia for research purposes. The permits were granted by the Australian Government’s Department of Health, allowing shipment from Canada by Aurora Cannabis Enterprises Inc., a wholly owned subsidiary of Aurora Cannabis Inc.

Preveceutical’s research program will be conducted at the University of Queensland’s Pharmacy Australia Centre of Excellence (“PACE”), a leading center for pharmaceutical research, education and commercialization. PACE has been granted the permits to import the dried cannabis flower and oils that will be used in the company’s innovative soluble gel (Sol-gel) drug delivery research program. It will be led by Dr. Harendra Parekh, chief research officer of PreveCeutical. The research team will test a range of cannabis strains to determine candidacy for the development and commercialization of cannabinoid-based Sol-gels.

The primary goal of the research program is to develop a nose-to-brain delivery system that will increase the bioavailability of active drug ingredients. The focus of the research is to apply Sol-gel technology to develop cannabinoid-based therapies for the relief of symptoms associated with pain, inflammation, seizures and neurological disorders. In a news release detailing the announcement, Stephen Van Deventer, chairman and CEO of PreveCeutical, said, “We are extremely excited to receive the Permits, allowing us to further our Sol-gel research program with the high quality cannabis products provided by Aurora. The goal of the Program is to cultivate a range of therapies that will benefit people with ailments such as epilepsy, pain and inflammation, safely and economically.”

“We see an important market for cannabis-based products that are more narrowly targeted at specific therapeutic areas but that are higher value add and being involved with initiatives such as PreveCeutical’s is part of our strategy to gain access to these types of products,” added Terry Booth, CEO of Aurora.

PreveCeutical believes that its cannabinoid-based nose-to-brain delivery technology, using a Sol-gel platform, will be the first to gain Food and Drug Administration approval. Its water soluable, alcohol free nasal formulation which will be developed for use by adults, children and people of certain beliefs.

PreveCeutical’s groundbreaking Sol-gel delivery system displays significant benefits over other contemporary delivery systems. It bypasses first pass metabolism in the stomach, intestines and liver, exhibiting a dramatic improvement in bioavailability, even compared to nasal sprays and alternative delivery mechanisms. Unlike other delivery systems, PreveCeutical’s Sol-gel delivery technology enables ease of application and provides long-lasting effects, all while eliminating negative side effects.

This latest research initiative comes on the back of established innovative solutions for preventive and curative therapies. The company’s first product, CELLB9®, is a Caribbean blue scorpion venom-based product that has been successfully marketed and distributed worldwide. PreveCeutical is currently in the development phase of a product based on this venom for the treatment, regulation and prevention of cancer progression. The company is also developing solutions based on the peptides derived from Caribbean blue scorpion venom for pain management, cancers, cardiovascular conditions, metabolic disorders and infectious diseases.

For more information, visit the company’s website at www.PreveCeutical.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Acquisitions and Growth Expand in Canadian Cannabis Market

CannabisNewsWire Editorial Coverage: The first wave of companies to enter the Canadian cannabis industry were grounded in medical marijuana, which was legalized in 2001. As the country prepares for legalized adult recreational-use this summer, new recreational brands are joining the scene, and many companies rooted in medicinal cannabis are taking action to participate in this second wave of the Canadian market. With its strong branding and modern store design, Choom Holdings, Inc. (CSE: CHOO) (OTCQB: CHOOF) (CHOOF Profile) is branded to appeal to the Canadian adult consumer ready to experience the cannabis lifestyle. Aurora Cannabis, Inc. (TSX: ACB) (OTCQB: ACBFF) is making strategic investments to establish footing in the recreational sector, while OrganiGram Holdings, Inc. (TSXV: OGI) (OTCQB: OGRMF) is taking measures to increase its production capacity ahead of a surge in product demand. Supreme Cannabis Company, Inc. (TSXV: FIRE) (OTC: SPRWF) has entered into multimillion-dollar agreements to supply cannabis to retail-oriented companies, and in Quebec, Hydropothecary Corp. (TSXV: THCX) is expanding its greenhouse capacity to potentially increase its cannabis production to 30x its current volume.

Highs Coming for Canadian Cannabis

As established companies get serious about brand expansion, supply agreements, and potential retail revenues, investments within Canada’s cannabis sector are soaring. The industry saw $1.2 billion investments in January alone – a 600 percent increase over the previous year – setting an incredible pace for continued growth. Currently, the State of California is the largest legal cannabis market in the world. With a population nearly as large as California’s and an influx of cannabis capital, Canada is on track to potentially become one of the world’s largest recreational-use markets. The country’s combined medicinal and recreational market size is expected to reach $6 billion by the year 2021, surpassing the value of its whiskey and spirits industry.

While the Canadian cannabis industry has found impressive success with medicinal marijuana in recent years, a different approach will be needed to target recreational consumers. Cannabis producers that recognize this tremendous potential are pursuing investments in recreational brands that appeal to the retail market. One of Canada’s most recognizable cannabis producers, Aphria, Inc. (TSXV: APH) (OTC: APHQF), recently shelled out $230 million to acquire recreational brand Broken Coast – one of many M&A deals within the burgeoning industry.

A Relaxed Brand for a Relaxing Product

One of the new companies looking to stake a claim in the recreational market is Choom Holdings, Inc. (CSE: CHOO) (OTCQB: CHOOF). Choom is based in British Columbia, though its hip, modern brand has been designed around the tropical, relaxed ambiance of Hawaii. The company’s name, “Choom”,  and style invoke Hawaiian culture, in particular easy days on the beach and in the countryside enjoying a casual atmosphere that connects with relaxation, which fittingly is one of the main appeals of cannabis. The company’s name, Choom, which means “to smoke marijuana” – comes from a slang word used by a fun-loving group of friends (including former U.S. President Barack Obama) who grew up together in Hawaii during the 1970s.

This relaxed, friendly and informal approach to selling cannabis is designed to tap into a younger market with socially liberal values and disposal income to spare, and differs radically from the marketing focus of medical marijuana companies. The look and feel more closely resembles a food or alcoholic beverage brand, evoking warm feelings instead of healing/medicinal properties, which are the focus of established brands. In short, it’s exactly the sort of approach the recreational cannabis industry will need.

Moving forward, the advantage in the legal cannabis sector seems likely to go to companies such as Choom, which are able to innovate with their branding, creating appealing lifestyle choices. Strict limitations on advertising cannabis will prevent the big medical marijuana players from using their financial clout to dominate the market through saturation advertising, which will create a space for young brands such Choom to grow via agile, modern techniques where traditional approaches aren’t an option.

From Seed to Sale

Choom appears to have another market advantage with its vertical integration. The business has a seed-to-sale model that covers the whole cannabis pipeline, from growing and processing the plants to selling the final product in its own stores. This control over the entire business process allows the company to maximize efficiencies and ensure integration along the supply chain.

This advantage starts in the growing facilities, where Choom will fully oversee the growth of carefully crafted strains of cannabis. Existing facilities are planned for Vernon and Chemainus, Canada, to ensure that the company is prepared for the market as soon as possible. Choom is refitting both facilities, a process scheduled to be complete by July, with more than 13,000 square feet of growing space in planning.

Choom has announced a clear plan for its move into this market. With the Canadian cannabis market expected to see dramatic growth in early stages, the company has capacity to expand as needed. A second phase of expansion is in place for both facilities, which will significantly increase the growing space and allow for doubling crop yields by early 2019.

At the sale end of this supply chain are Choom’s dispensaries, which are designed with a clean, stylish, and modern feel, much like a more relaxed version of an Apple store, a favorite of millennials and those with disposable income. These stores have been envisioned to appeal to two different but important market sectors. One is existing cannabis users, who will be looking for more convenient ways to buy their product once the law changes. The other is the group of “curious customers,” who weren’t willing to use cannabis while it was illegal but are interested in trying it now. Choom’s relaxing retail space is designed to draw in customers from both sides, quickly building up a strong high street brand.

Preparing for Change

To power further growth, the company also recently completed a financing initiative, exceeding expectations and raising CAD $2.7 million (http://cnw.fm/AkT9x). The funds are being invested in advancing the company’s development strategy, as well as for growth and acquisitions.

Having recently released the retail design for its dispensaries (http://cnw.fm/DIl3r), Choom is readying those facilities ready for legalization as well.  And with the official launch of its retail program, the company has created the opportunity to develop a chain of branded cannabis dispensaries across Canada (http://cnw.fm/jqn8I).

“Choom is using design and retail strategies that have worked successfully at some of the most profitable storefronts in the country. We are telling our Choom story with our stores and will elevate the concept of a high-quality product though our new retail environments, and we’re inviting others to join us,” Choom president and CEO Chris Bogart stated in the press release.

As the legal cannabis market prepares to open in Canada, Choom appears to have all the pieces in place to create a national premium recreation brand.

A Sector in Waiting

As the creation of Canada’s legal recreational cannabis sector approaches, other companies are also preparing for the change.

One of Canada’s biggest cannabis producers, Aurora Cannabis (TSX: APH) (OTCQB: APHQF), is investing in a range of related companies to set itself up for expansion into the recreational sector. The Vancouver-based organization has invested in The Green Organic Dutchman, a company that produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. It has also teamed up with Liquor Stores NA Ltd. (TSX: LIQ) to convert existing retail outlets into cannabis retail stores.

Another licensed producer of medical marijuana, OrganiGram Holdings (TSXV: OGI) (OTCQB: OGRMF), recently received an expanded cultivation license from Health Canada, enabling the company to move forward with its expansion strategy that would increase current capacity from approximately 5,200 kg/year to an estimated 16,000 kg/year. Its longer-term plan is to increase production to 65,000 kg/year over the next two years.

Supreme Cannabis Company (TSXV: FIRE) (OTC: SPRWF) has made its mission to grow sustainable cannabis companies to cater to the growing recreational market. To this end, it has invested in late-stage ACMPR applicant company BlissCo, and has agreed to provide cannabis to that company through its 7ACRES subsidiary. 7ACRES will also supply cannabis to Namaste (CSE: N) (FRA: M5BQ) (OTC: NXTTF) subsidiary, Cannmart.

Quebec-based Hydropothecary (TSXV: THCX) has signed a letter of intent with Société des alcools du Québec (SAQ) to supply 20,000 kg of cannabis to Quebec’s recreational cannabis market in its first year of operation. This recent announcement follows news in December that the company added 78 acres of land adjacent to its existing 65-acre facility, and that it is working on a 1 million-square-foot greenhouse designed to increase its production to 108,000 kg per year, 30 times the current capacity.

Based on all forecasts, Canada’s cannabis market is set for significant expansion in 2018. New actors and existing medical companies alike are preparing to seize this opportunity through production, distribution, and retail growth. With a clearly defined growth strategy, Choom Holdings is demonstrating its intention to rapidly become a recognizable national brand.

For more information on Choom Holdings, please visit Choom Holdings, Inc. (CSE: CHOO) (OTCQB: CHOOF)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

The Green Organic Dutchman is Farming One Million Square Feet of Organic Cannabis as Supply Shortfall Looms

  • Focused on medical market with organic marijuana
  • Large scale production to reap benefits from economies of scale
  • Partnerships with utilities to lower power costs

As one of just two producers of organic cannabis and with a million square feet of low cost production planned, the Green Organic Dutchman Holdings Ltd. (“TGOD”) is set to capitalize on Canada’s looming supply shortfall. The company is growing its competitive advantage in a way that appears to run contrary to established dictum by focusing not just on differentiation but also on cost leadership. Typical generic strategies are either one or the other. This unique approach is winning friends and influencing people. TGOD has, to date, closed $112 million in private placements, which includes $55 million from marijuana industry powerhouse Aurora Cannabis Inc. (OTCQX: ACBFF) (TSX: ACB). As Canada draws closer to legalization of the consumer market, TGOD is looking good. The company’s highly anticipated IPO is planned for March 2018.

Writing in the 1980s, renowned Harvard professor Michael Porter excited attention with his theory of how companies should pursue the elusive grail of competitive advantage. A company’s basic strategy should be based, he argued, either on producing at a lower cost than its competitors can or on differentiating itself by offering unique features. A company should also decide on market scope by selling to selected market segments or to the broad market.

As a guide, Porter’s analysis helps to develop strategic focus. However, real world conditions often blur the dichotomy between the cost and differentiation strategies that he detailed. While TGOD can attempt some differentiation by its concentration on organic methods of cultivation, such methods are obviously not unique to the company, which is why a hybrid approach may be the right one. As a result, TGOD is pursuing a low cost strategy in the limited scope market segment of organic cannabis.

The low cost aspect of its mixed strategy has a good chance of succeeding. The company’s production operations in Ontario and Quebec together command 970,000 square feet of ultra-high technology greenhouse facilities. With such a mammoth scale in play, TGOD should benefit from large economies of scale. Moreover, TGOD has an agreement with Eaton Corp., the $36 billion global power management company, under which Eaton, by providing research and optimization, will allow TGOD to have some of the lowest electricity input costs in the business. The collaboration has facilitated the development of a six-megawatt cogeneration natural gas power plant on TGOD’s Ontario property, which is expected to drive kilowatt-hour cost down from its present $0.13 to $0.045.

At that Hamilton, Ontario, facility, TGOD is planning a two-phased approach, under which annual production will be expanded from 1,000 kilograms per year to 14,000 kilograms by the end of 2018. At $8 a gram, this translates to revenues of $112 million. Total build-out capacity to achieve that output will be 150,000 square feet. The operation currently consists of a 1,000 kilogram-per-year indoor production facility, which acts as a beta facility for the larger expansion.

Construction at facilities located on TGOD’s 75-acre property in Quebec has begun. The facility covers an extensive 820,000 square feet capable of producing 102,000 kilograms of organic cannabis. The first phase of this expansion is underway, and construction is expected to be completed by Q2 2019. This first phase will consist of 220,000 square feet capable of producing 22,000 kilograms of cannabis. Second and third phases, which will add 250,000 square feet producing 26,000 kilograms of cannabis and 350,000 square feet producing 54,000 kilograms of cannabis, are expected to follow.

For more information, visit the company’s website at www.TGOD.ca

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

The Green Organic Dutchman’s Strategy Ensures Sustainable Future Growth

  • The Green Organic Dutchman raised $112 million to fund 970,000 square foot expansion of cannabis cultivation facilities in 2018
  • This includes $55 million investment by Aurora Cannabis Inc.
  • Strategy positions The Green Organic Dutchman to be one of the world’s largest, most technically advanced cannabis producers

Headquartered in Hamilton, Ontario, The Green Organic Dutchman Holdings Ltd., known as “TGOD”, has formed strategic alliances with industry leaders with a view to becoming the world’s largest organic cannabis company. To achieve this goal, the company has taken an approach unique in the cannabis industry, by growing cannabis organically at a low cost, expanding its cultivation facilities to scale, hiring world class senior management and forming strategic partnerships with major players, including Eaton Corp. (one of the world’s largest power management companies) to lower electricity costs and Ledcor Group, the second-largest and one of most respected construction companies in Canada.

TGOD cultivates farm-grown, organic and synthetic pesticide-free medical cannabis using all natural, organic craft growing principles. The company is licensed to produce medical cannabis under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”). TGOD is currently performing a 970,000 square foot expansion to its cultivation facilities, which will enable the company to produce 116 tons of cannabis annually. This expansion project is scheduled to come online in phases, beginning in 2018, to meet the increased demand expected with the legalization of recreational cannabis throughout Canada.

TGOD recently announced that it had secured $112 million in private placement financing, including a $55 million strategic investment by Aurora Cannabis Inc. (OTCQX: ACBFF) (TSX: ACB), an established company in the marijuana industry. This investment will fully fund TGOD’s planned expansion. Its strategic partnership with Aurora positions TGOD’s cannabis production facilities to be among the largest and most technically advanced in the world.

The project management consortium for this expansion includes Eaton Corp. and Ledcor, who will report to TGOD management on project progress. Both of these companies have extensive international experience in power, project and construction management. Eaton devises energy-efficient solutions for the efficient management of electrical, hydraulic and mechanical power. Ledcor will ensure an accelerated production schedule by using advanced multidisciplinary design/build processes and implementing scalable operational and project plans. These companies will deploy their world-class project teams to ensure that the projects are completed on time and on budget.

With this massive expansion to its facilities in Ontario and Quebec, and by leveraging innovative technology and low-cost power solutions, TGOD could be positioned as one of the most cost-efficient, high-quality cannabis producers in Canada. The company has formed an alliance partnership with Hamilton Utility Corp., which has enabled it to reduce its power cost from $0.13 per kWh to less than $0.05 per kWh. TGOD’s position as a low-cost cannabis producer will be strengthened in Quebec, the province with the lowest power rates in Canada, which can be as low as $0.04 per kWh.

TGOD also plans to secure a share of the growing cannabis oils market. It has commissioned a purpose-built extraction laboratory, a commercial-scale CO2 extraction unit which can process up to 12,000 kg of raw material per year for the production of around $170 million worth of organic cannabis oils. Cannabis oil is a critical raw material for the production of several recreational market verticals, including topicals, edibles, concentrates and beverages.

The company has a world-class management team with proven executive and operational experience in the cannabis, consumer products, consumer packaged goods (CPG) and finance industries. Plans for a public listing with the Toronto Stock Exchange are underway, with the launch of an initial public offering (IPO) expected imminently.

For more information, visit the company’s website at www.TGOD.ca

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Strategic Partnerships Elevate The Green Organic Dutchman’s Premium Cannabis To Heady Future

  • Closing of $112 million in private placement financing fully funds expansion plans
  • Time-to-market accelerated as Aurora Cannabis inks strategic investment/partnership with TGOD
  • Highly anticipated IPO scheduled for March 2018
  • Organic, medical-grade cannabis grown at low cost increases profit margins

The Green Organic Dutchman Holdings Ltd. (“TGOD”) continues to make headlines as it forms strategic partnerships and banks investment funds to fuel the company’s expansion plans to become the largest organic cannabis company in the world. The company’s recent announcement of its closing of $112 million in private placement financing included a cornerstone investment of $55 million by marijuana industry powerhouse Aurora Cannabis Inc. (OTCQX: ACBFF) (TSX: ACB) (http://cnw.fm/5lHaB). To date, TGOD has raised $160 million with over 4,000 shareholders.

TGOD is setting the industry standard on several fronts, including environmental stewardship, natural resource sustainability and development of a consortium of world-class architectural, construction and utility management teams dedicated to responsible practices. As a Canadian licensed cannabis producer, TGOD prides itself on growing completely organic, pesticide-free, grown-in-live-soil cannabis. In an interview with Equities.com (http://cnw.fm/uL0cG), Danny Brody, TGOD’s vice president of investor relations, said that he believes the company’s commitment to growing medical grade cannabis sets it apart.

“From day one we believed that organic product is key,” Brody stated. “That is one of our key differentiators that we will be continuing as we build out our operation.”

With this new infusion from investors, TGOD is able to fully fund a 970,000 square foot expansion of its organic cannabis production facilities located in Ontario and Quebec, two of Canada’s most populated provinces. The facilities, capable of producing 116,000 kg of cannabis annually, are slated to come online in Q4 2018 and Q2 2019, respectively. While medical marijuana has been legal in Canada since 2001 and is projected to grow to $2.1 billion by 2020, the recreational marijuana market is expected to reach $22 billion by 2024, according to a Deloitte report (http://cnw.fm/vdFR1).

The “Canadian Advantage” is real and the opportunities are unparalleled, both in Canada and internationally, as TGOD management noted in its latest corporate presentation to shareholders. As the first G7 nation poised to legalize recreational marijuana use, Canada is having a profound impact on legalization efforts around the world. In contrast, there are 29 states in the U.S. that currently allow some form of marijuana use, although there are measures on several ballots that could add legal cannabis to the lawbooks in additional states in the near future (http://cnw.fm/Phxu6). John Kagia, a cannabis industry analyst for New Frontier Data, called the recent move toward Canadian legalization a “wake up call to all investors who were sitting on the sidelines, that this is really going to happen.”

Although full implementation of legal cannabis for adults in Canada is expected to be in place by July 2018, there is some waffling on the timing, as legislation allowing for recreational cannabis must still pass Parliament (http://cnw.fm/Sw33v). Health Minister Ginette Petitpas Taylor said lower levels of government have informed her that more time – as much as eight to 12 weeks – may be required following adoption of the law (http://cnw.fm/1Do8B).

Timing is important, as TGOD is proving with its recent investment news and early spring 2018 plans to transition from a privately-held company to a publicly-traded one. TGOD believes that its unique approach to producing high quality, pharma-grade cannabis, coupled with its solid commitment to core values, offers numerous opportunities for additional joint ventures, licensing and distribution partnerships for a sustainable and successful future.

For more information, visit the company’s website at www.TGOD.ca

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net